PeptideStack
5.2kquestions
20kanswers
220users

harm-reduction

Page 2 of 19 · 445 questions tagged harm-reduction.

445 questions · sorted by votes · page 2 of 19

38 votes5 answers38k views
Does the SURMOUNT-5 population resemble anyone asking about mazdutide here?

Stated plainly: SURMOUNT-5 · mazdutide. I have read the primary source rather than the summary, which has left me with more questions. I understand the headline. I do…

clinical-trials
clinical-trials

Reading the primary literature properly: estimands, intention-to-treat versus per-protocol, confidence intervals, absolute versus relative…

913 questions
harm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

445 questions
semaglutide
semaglutide

A GLP-1 receptor agonist with a fatty-acid-acylated backbone and a roughly one-week half-life, marketed for type 2 diabetes and for weight…

360 questions
asked by birk_nordahl 20k · 21 months ago
38 votes0 answers31k views
Is a domestic freezer good enough for storing reconstituted mazdutide?

Setup, so nobody has to ask: a domestic freezer · mazdutide. I would like to set this up properly once, rather than adjust it repeatedly. My budget is real but not…

storage
storage

Storage conditions and their evidence base: minus twenty degrees for powder, refrigerated for solution, protection from light, and what the…

646 questions
cold-chain
cold-chain

Keeping material within a temperature window from manufacture to use: phase-change packs versus dry ice, thermal mass, transit-lane temperature…

524 questions
harm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

445 questions
asked by area_percent 13k · 21 months ago
38 votes5 answers23k views
What would make you reject a WWB vial on visual inspection alone?

I keep a written log of every draw with date, volume and syringe type. This is a planning question. I know what my options are; I do not know how to weigh them. What…

vial-inspection
vial-inspection

What you can learn by looking: cake morphology, meniscus films, fibres versus stopper fragments versus true particulates, clarity after…

66 questions
harm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

445 questions
sterility
sterility

Sterility as a test result rather than an adjective. Covers what a sterility test actually measures, why "sterile filtered" on a document is close…

122 questions
asked by cake_collapsed 13k · 17 months ago
38 votes 5 answers19k views
Is LDL-C worth drawing at baseline before starting cagrilintide?

What I am working with: LDL-C · cagrilintide. I would like to set this up properly once, rather than adjust it repeatedly. My budget is real but not tight, and my…

bloodwork
bloodwork

Laboratory monitoring: which panels are worth ordering, sensible intervals, reference-range versus optimal-range arguments, and how to read a…

284 questions
harm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

445 questions
a1c
a1c

Glycated haemoglobin as a ninety-day glycaemic average: what a change of half a point means, why it lags, and the conditions under which it…

108 questions
asked by bufferline42 49k · 22 months ago
37 votes 5 answers80k views
Does the SURMOUNT-3 population resemble anyone asking about semaglutide here?

The particulars: SURMOUNT-3 · semaglutide. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that I am…

clinical-trials
clinical-trials

Reading the primary literature properly: estimands, intention-to-treat versus per-protocol, confidence intervals, absolute versus relative…

913 questions
harm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

445 questions
semaglutide
semaglutide

A GLP-1 receptor agonist with a fatty-acid-acylated backbone and a roughly one-week half-life, marketed for type 2 diabetes and for weight…

360 questions
asked by forty_units 14k · 2.3 years ago
37 votes 5 answers57k views
Is a date of analysis from TFC sufficient basis to skip independent testing?

The specifics, since they change the answer: date of analysis · TFC. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan…

coa
coa

Certificates of analysis: what fields a useful one carries, how to tell a real analytical report from a marketing document, batch and lot…

749 questions
batch-testing
batch-testing

Testing at the batch or lot level: sampling plans, how many vials from a lot need testing to say anything about the lot, and the difference…

865 questions
harm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

445 questions
asked by Dr_Otto_Lindqvist 38k · 2.2 years ago
37 votes5 answers50k views
Does the SURMOUNT-3 population resemble anyone asking about retatrutide here?

Numbers first: SURMOUNT-3 · retatrutide. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…

clinical-trials
clinical-trials

Reading the primary literature properly: estimands, intention-to-treat versus per-protocol, confidence intervals, absolute versus relative…

913 questions
harm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

445 questions
semaglutide
semaglutide

A GLP-1 receptor agonist with a fatty-acid-acylated backbone and a roughly one-week half-life, marketed for type 2 diabetes and for weight…

360 questions
asked by anja_hellstrom 13k · 17 months ago
37 votes0 answers21k views
What should be in place before a first tirzepatide vial arrives from Shanghai?

The specifics, since they change the answer: tirzepatide · Shanghai. I am at the decision point and I would rather think it through than improvise. I would rather…

harm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

445 questions
research-use-only
research-use-only

What "for research use only" means as a legal and practical designation: not approved for human use, no pharmacopoeial release testing, no…

91 questions
sterility
sterility

Sterility as a test result rather than an adjective. Covers what a sterility test actually measures, why "sterile filtered" on a document is close…

122 questions
asked by eighty_six_hours 16k · 2.0 years ago
37 votes0 answers18k views
Is a sampling plan from ERP sufficient basis to skip independent testing?

Numbers first: sampling plan · ERP. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the minimum viable…

coa
coa

Certificates of analysis: what fields a useful one carries, how to tell a real analytical report from a marketing document, batch and lot…

749 questions
batch-testing
batch-testing

Testing at the batch or lot level: sampling plans, how many vials from a lot need testing to say anything about the lot, and the difference…

865 questions
harm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

445 questions
asked by one_ml_bac 12k · 21 months ago
37 votes3 answers11k views
Does site rotation actually have evidence behind it, and what kind of reaction warrants stopping?

Two related questions I cannot get straight answers to. First, site rotation. Everyone says rotate, nobody says on what evidence or at what spacing. I have seen "2…

injection-site-reaction
injection-site-reaction

Local reactions: erythema, induration, pruritus and nodules. Their relationship to injection depth, diluent composition, benzyl alcohol…

14 questions
injection-technique
injection-technique

Technique questions: angle, pinch versus flat, aspiration, injection speed, air bubbles, and the handling steps that determine whether you deliver…

90 questions
subcutaneous
subcutaneous

Subcutaneous administration as a route: absorption kinetics from abdomen versus thigh versus upper arm, tissue depth, and why site rotation…

14 questions
harm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

445 questions
asked by klara_novotna 16k · 36 days ago
36 votes 5 answers54k views
Would a colour change alone justify discarding a vial?

I have photographs before and after reconstitution if the visual detail matters. I would like to set this up properly once, rather than adjust it repeatedly. My…

vial-inspection
vial-inspection

What you can learn by looking: cake morphology, meniscus films, fibres versus stopper fragments versus true particulates, clarity after…

66 questions
peptide-stability
peptide-stability

The chemistry of peptide degradation: deamidation, oxidation, hydrolysis, aggregation and fibrillation, and how temperature, pH, ionic strength,…

832 questions
harm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

445 questions
asked by mz_4113 99k · 2.3 years ago
36 votes5 answers45k views
Does the SURMOUNT-4 population resemble anyone asking about liraglutide here?

Conditions: SURMOUNT-4 · liraglutide. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the specifics…

clinical-trials
clinical-trials

Reading the primary literature properly: estimands, intention-to-treat versus per-protocol, confidence intervals, absolute versus relative…

913 questions
harm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

445 questions
semaglutide
semaglutide

A GLP-1 receptor agonist with a fatty-acid-acylated backbone and a roughly one-week half-life, marketed for type 2 diabetes and for weight…

360 questions
asked by drawn_and_capped 15k · 23 months ago
36 votes 5 answers33k views
What is a sensible monitoring routine for ecnoglutide over four weeks?

Concretely: ecnoglutide · four weeks. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months in view and I would like the…

bloodwork
bloodwork

Laboratory monitoring: which panels are worth ordering, sensible intervals, reference-range versus optimal-range arguments, and how to read a…

284 questions
harm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

445 questions
plateau
plateau

A stall in progress: distinguishing adaptive thermogenesis from measurement error from adherence drift, how long to observe before changing…

35 questions
asked by per_haugen 18k · 22 months ago
36 votes 4 answers33k views
Does the STEP 3 population resemble anyone asking about a GLP-1 receptor agonist here?

Setup, so nobody has to ask: STEP 3 · a GLP-1 receptor agonist. I have read the primary source rather than the summary, which has left me with more questions. I…

clinical-trials
clinical-trials

Reading the primary literature properly: estimands, intention-to-treat versus per-protocol, confidence intervals, absolute versus relative…

913 questions
harm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

445 questions
semaglutide
semaglutide

A GLP-1 receptor agonist with a fatty-acid-acylated backbone and a roughly one-week half-life, marketed for type 2 diabetes and for weight…

360 questions
asked by s_kalniete 47k · 2.0 years ago
35 votes5 answers45k views
What accept/reject threshold would you set for tirzepatide before seeing the result?

I have both a purity figure and a content figure, which is why the discrepancy is visible. I am at the decision point and I would rather think it through than…

batch-testing
batch-testing

Testing at the batch or lot level: sampling plans, how many vials from a lot need testing to say anything about the lot, and the difference…

865 questions
harm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

445 questions
coa
coa

Certificates of analysis: what fields a useful one carries, how to tell a real analytical report from a marketing document, batch and lot…

749 questions
asked by second_lot 11k · 18 months ago
35 votes5 answers41k views
Does the SURMOUNT-OSA population resemble anyone asking about retatrutide here?

What I have: SURMOUNT-OSA · retatrutide. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to…

clinical-trials
clinical-trials

Reading the primary literature properly: estimands, intention-to-treat versus per-protocol, confidence intervals, absolute versus relative…

913 questions
harm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

445 questions
semaglutide
semaglutide

A GLP-1 receptor agonist with a fatty-acid-acylated backbone and a roughly one-week half-life, marketed for type 2 diabetes and for weight…

360 questions
asked by bufferline42 49k · 23 months ago
35 votes 5 answers36k views
How would I detect deamidation in an ecnoglutide vial without sending it to Medutest?

The specifics, since they change the answer: deamidation · ecnoglutide · Medutest. I have read the obvious sources and they disagree with each other, so I would…

vial-inspection
vial-inspection

What you can learn by looking: cake morphology, meniscus films, fibres versus stopper fragments versus true particulates, clarity after…

66 questions
peptide-stability
peptide-stability

The chemistry of peptide degradation: deamidation, oxidation, hydrolysis, aggregation and fibrillation, and how temperature, pH, ionic strength,…

832 questions
harm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

445 questions
asked by mg_per_ml 12k · 23 months ago
35 votes0 answers33k views
What interval makes sense for repeating potassium on semaglutide?

The particulars: potassium · semaglutide. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with explicit stopping…

bloodwork
bloodwork

Laboratory monitoring: which panels are worth ordering, sensible intervals, reference-range versus optimal-range arguments, and how to read a…

284 questions
harm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

445 questions
a1c
a1c

Glycated haemoglobin as a ninety-day glycaemic average: what a change of half a point means, why it lags, and the conditions under which it…

108 questions
renal-outcomes
renal-outcomes

Kidney endpoints: the FLOW composite, eGFR slope as an endpoint, albuminuria regression, and why an early eGFR dip is expected rather than alarming.

14 questions
asked by greta_holzmann 15k · 23 months ago
35 votes 2 answers20k views
What is a sensible monitoring routine for cagrilintide over six weeks?

Details up front: cagrilintide · six weeks. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the minimum…

bloodwork
bloodwork

Laboratory monitoring: which panels are worth ordering, sensible intervals, reference-range versus optimal-range arguments, and how to read a…

284 questions
harm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

445 questions
plateau
plateau

A stall in progress: distinguishing adaptive thermogenesis from measurement error from adherence drift, how long to observe before changing…

35 questions
asked by dead_volume 49k · 2.2 years ago
35 votes 5 answers18k views
What should be in place before a first a GLP-1 receptor agonist vial arrives from Shanghai?

What I have: a GLP-1 receptor agonist · Shanghai. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the minimum…

harm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

445 questions
research-use-only
research-use-only

What "for research use only" means as a legal and practical designation: not approved for human use, no pharmacopoeial release testing, no…

91 questions
sterility
sterility

Sterility as a test result rather than an adjective. Covers what a sterility test actually measures, why "sterile filtered" on a document is close…

122 questions
asked by Dr_Ingrid_Baumgartner 39k · 22 months ago
35 votes0 answers13k views
What would make you reject an ERP vial on visual inspection alone?

For context, I am working with a 10 mg presentation and a 2 mL fill. I am trying to build something sustainable rather than something thorough that I will abandon. I…

vial-inspection
vial-inspection

What you can learn by looking: cake morphology, meniscus films, fibres versus stopper fragments versus true particulates, clarity after…

66 questions
harm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

445 questions
sterility
sterility

Sterility as a test result rather than an adjective. Covers what a sterility test actually measures, why "sterile filtered" on a document is close…

122 questions
asked by drawn_and_capped 15k · 16 months ago
35 votes0 answers12k views
Is a chromatogram from GL Biochem sufficient basis to skip independent testing?

Concretely: chromatogram · GL Biochem. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months in view and I would like the…

coa
coa

Certificates of analysis: what fields a useful one carries, how to tell a real analytical report from a marketing document, batch and lot…

749 questions
batch-testing
batch-testing

Testing at the batch or lot level: sampling plans, how many vials from a lot need testing to say anything about the lot, and the difference…

865 questions
harm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

445 questions
asked by Dr_Fatima_Belkacem 52k · 17 months ago
34 votes 5 answers70k views
Is a domestic freezer good enough for storing reconstituted liraglutide?

The case in front of me: a domestic freezer · liraglutide. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months in view and…

storage
storage

Storage conditions and their evidence base: minus twenty degrees for powder, refrigerated for solution, protection from light, and what the…

646 questions
cold-chain
cold-chain

Keeping material within a temperature window from manufacture to use: phase-change packs versus dry ice, thermal mass, transit-lane temperature…

524 questions
harm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

445 questions
asked by tamsin_wray 13k · 2.4 years ago
34 votes 5 answers67k views
How do I photograph a vial so someone can actually assess it?

I have photographs before and after reconstitution if the visual detail matters. Everything I have found on this is either a forum aside or a product page, neither of…

vial-inspection
vial-inspection

What you can learn by looking: cake morphology, meniscus films, fibres versus stopper fragments versus true particulates, clarity after…

66 questions
reconstitution
reconstitution

Taking a lyophilised vial to a solution of known concentration: choice of diluent, volume selection, how to add liquid without shearing the cake,…

330 questions
harm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

445 questions
asked by ben_akintola 14k · 2.4 years ago